Arsthinol

DB08928ExperimentalSmall molecule

Arsthinol (INN) is an antiprotozoal agent that was first synthesized by Ernst A.H. Friedheim in 1949 via the complexing of acetarsol with 2,3-dimercaptopropanol. It has since been demonstrated that the... Considered well tolerated when compared to other related trivalent organoarsenicals, arsthinol has even undergone recent studies as a potential anticancer agent.

Primary indication: Antiprotozoal agent effective against amoebiasis and yaws.Curator reviewed
Formula / weight: C₁₁H₁₄AsNO₃S₂ · 347.285 g/mol (avg)
Also known as: Arsthinenol

Resolves to

Compound

UNIIQNT09A162YCAS119-96-0ChEMBLCHEMBL1788384ChEBI135465PubChem8414KEGGD07356

Clinical / RWD

ATCP01AR01

Structure

InChIKeyMRUDSZSRLQAPOG-UHFFFAOYSA-NSMILESCC(=O)NC1=CC(=CC=C1O)[As]1SCC(CO)S1

What you can answer from here — as of February 21, 2021

1ATC codeIncluding every combination product, plus 3 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Arsthinol, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account